Brief: AngioDynamics Q3 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.14
04/04/2024 12:00
Apr 04 (Reuters) - AngioDynamics Q3 adjusted EBITDA USD -3.6 million. * Q3 sales USD 66 million vs. IBES estimate USD 75.7 million * Q3 adjusted net income USD -6.5 million vs. IBES estimate USD -5.64 million * Q3 gross margin 47.7% * Q3 net income USD -190.4 million * outlook FY gross margin 52-54% * outlook FY sales USD 270-275 million
Recent news on AngioDynamics
See all newsAngioDynamics, Inc. reports results for the quarter ended August 31 - Earnings Summary
AngioDynamics Q1 sales beat on med tech segment growth
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
AngioDynamics Inc reports results for the quarter ended May 31 - Earnings Summary